The Analysis Study of Effectiveness of Oral Isotretinoin for Treatment of Mucocutaneous Human Papilomavirus Infections : A Comprehensive Systematic Review

The Analysis Study of Effectiveness of Oral Isotretinoin for Treatment of Mucocutaneous Human Papilomavirus Infections : A Comprehensive Systematic Review

Authors

  • Putu Mahadevy Pradnyandhari Putri Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
  • Made Krisna Wibawa Pramartha Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia

Keywords:

Isotretinoin, retinoid, human papilloma virus, infection, mucocutaneous

Abstract

Background: Oral isotretinoin (13-cis-retinoic acid) is a retinoid, derivedfrom vitamin A. Warts constitute the most frequently observed dermatological manifestations of human papillomavirus (HPV). The aim: The aim of this study to show about oral isotretinoin for treatment of mucocutaneous human papillomavirus infection. Methods: By the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. This search approach, publications that came out between 2014 and 2024 were taken into account. Several different online reference sources, like Pubmed, SagePub, and Sciencedirect were used to do this. Result: Eight publications were found to be directly related to our ongoing systematic examination after a rigorous three-level screening approach. Subsequently, a comprehensive analysis of the complete text was conducted, and additional scrutiny was given to these articles. Conclusion: low dose oral isotretinoin when combined with topical tretinoin 0.1% can be superior to low dose oral isotretinoin alone in terms of faster resolution of lesions in addition to complete clearance with minimal side effect profile.

References

Forbat E, Ali FR, Al-Niaimi F. Dermatological indications for the use of isotretinoin beyond acne. J Dermatolog Treat [Internet]. 2018;29(7):698–705. Available from: https://doi.org/10.1080/09546634.2018.1445194

Melnik BC. Apoptosis may explain the pharmacological mode of action and adverse effects of isotretinoin, including teratogenicity. Acta Derm Venereol. 2017;97(2):173–81.

Miljković J. A novel therapeutic approach to plane warts: A report on two cases. Acta Dermatovenerologica Alpina, Pannonica Adriat. 2012;21(3):63–4.

Brzezinski P, Wollina U, Smigielski J, Borowska K. The use of isotretinoin in acne therapy in early childhood and its effect on the occurrence of acne symptoms later in life. Eight-year follow-up. Postep Dermatologii i Alergol. 2022;39(4):682–7.

Pugalia N, Singh AL, Chandak M. Treatment Modalities of Cutaneous and Genital Warts: A Narrative Review. J Clin Diagnostic Res. 2023;17(7):1–5.

Ramchatesingh B, Martínez Villarreal A, Arcuri D, Lagacé F, Setah SA, Touma F, et al. The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review. Int J Mol Sci. 2022;23(20).

Bagatin E, Costa CS, Rocha MAD da, Picosse FR, Kamamoto CSL, Pirmez R, et al. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology. An Bras Dermatol. 2020;95:19–38.

Sherko, Marzieh Soheili S, Eili HK, Sohe MEN. Human p papillom ma virus : A review w study of o epidem miology , carcinog genesis , diagnost tic metho ods , and d treatme ent of all l HPV-re lated can ncers. Med J Islam Repub Iran(MJIRI). 2021;1–16.

Dave DD, Abdelmaksoud A. Low dose isotretinoin as an adjuvant therapy for treatment of different clinical variants of warts: A case series. Dermatol Ther. 2019;32(2):10–3.

Nooruldeen AD, Saeed MY. Efficacy and safety of oral isotretinoin in treatment of plane warts. Bali Med J. 2021;10(3):1076–80.

Olguín-García MG, Peralta-Pedrero ML, Jurado-Santa Cruz F, Vega-Memije E, Morales-Sánchez MA. Low-dose oral isotretinoin in the treatment of recalcitrant facial flat warts: A clinical case and review of literature. Heal Sci Reports. 2023;6(10):1–7.

Kaur GJ, Brar BK, Kumar S, Brar SK, Singh B. Evaluation of the efficacy and safety of oral isotretinoin versus topical isotretinoin in the treatment of plane warts: a randomized open trial. Int J Dermatol. 2017;56(12):1352–8.

Nofal A, Khedr A, Fathy M. Combined oral isotretinoin and Candida antigen versus either agent alone in the treatment of plane warts. J Dermatolog Treat [Internet]. 2022;33(1):342–7. Available from: http://dx.doi.org/10.1080/09546634.2020.1754325

Olguin-García MG, Cruz FJS, Peralta-Pedrero ML, Morales-Sánchez MA. A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts. J Dermatolog Treat. 2015;26(1):78–82.

Randhawa NK, Kumar S, Agarwal US, Agarwal P, Bansal A, Meena S. To Evaluate Efficacy and Safety of Low Dose Oral Isotretinoin ( 20 mg / Day ) Alone Versus Combination of Low Dose Oral Isotretinoin ( 20 mg / Day ) Plus Topical Tretinoin ( 0 . 1 %) in Gel Formulation in the Treatment of Verruca Plana. 2023;14(1000):1–7.

Mullen SA, Myers EL, Brenner RL, Nguyen KT, Harper TA, Welsh D, et al. Systematic Review of Intralesional Therapies for Cutaneous Warts. JID Innov [Internet]. 2024;4(3):100264. Available from: https://doi.org/10.1016/j.xjidi.2024.100264

Reyna-Rodríguez IL, Chavez-Alvarez S, Garza-Rodríguez V, Franco-Marquez R, Gonzalez-Martinez G, Ocampo-Candiani J, et al. Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial. Arch Dermatol Res [Internet]. 2021;313(10):815–27. Available from: https://doi.org/10.1007/s00403-020-02182-y

Nickle SB, Peterson N, Peterson M. Updated physician’s guide to the off-label uses of oral isotretinoin. J Clin Aesthet Dermatol. 2014;7(4):22–34.

Białecka A, Męcińska-Jundzill K, Adamska U, Cichewicz A, Białecki M, Drewa G, et al. Plane warts on the back of the hand successfully treated with oral isotretinoin. Postep Dermatologii i Alergol. 2018;35(2):227–9.

Troyanova-Slavkova S, Eickenscheidt L, Pönnighaus JM, Kowalzick L. Low-dose prophylactic oral isotretinoin treatment for 18 years in a patient with epidermodysplasia verruciformis and numerous squamous cell carcinomas. Hautarzt. 2018;69(12):1033–8.

Duvalyan A, Cha A, Goodarzian F, Arkader A, Villablanca JG, Marachelian A. Premature epiphyseal growth plate arrest after isotretinoin therapy for high-risk neuroblastoma: A case series and review of the literature. Pediatr Blood Cancer. 2020;67(8):1–9.

Yang TH, Lee TH, Huang YC. Oral isotretinoin for treating mucocutaneous human papillomavirus infections: A systematic review and meta-analysis. Indian J Dermatol Venereol Leprol [Internet]. 2019;85(6):569. Available from: https://ijdvl.com/oral-isotretinoin-for-treating-mucocutaneous-human-papillomavirus-infections-a-systematic-review-and-meta-analysis/

Zhu P, Qi RQ, Yang Y, Huo W, Zhang Y, He L, et al. Clinical guideline for the diagnosis and treatment of cutaneous warts (2022). J Evid Based Med. 2022;15(3):284–301.

Sivasankari M, Subramania Adityan M. Oral isotretinoin as first-line systemic therapy in a case of extensive genital warts. Indian J Sex Transm Dis AIDS. 2022;43(1):70–2.

Paichitrojjana A, Paichitrojjana A. Oral Isotretinoin and Its Uses in Dermatology: A Review. Drug Des Devel Ther. 2023;17(August):2573–91.

Downloads

Published

2024-08-17 — Updated on 2024-08-17

Versions

How to Cite

The Analysis Study of Effectiveness of Oral Isotretinoin for Treatment of Mucocutaneous Human Papilomavirus Infections : A Comprehensive Systematic Review (P. M. P. Putri & M. K. W. Pramartha , Trans.). (2024). The Indonesian Journal of General Medicine, 2(2), 57-71. https://doi.org/10.70070/vbv3gb47